Results 71 to 80 of about 423,962 (267)

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Decompositions of Complete Multipartite Graphs into Complete Graphs

open access: yes, 2011
Let $k\geq\ell\geq1$ and $n\geq 1$ be integers. Let $G(k,n)$ be the complete $k$-partite graph with $n$ vertices in each colour class. An $\ell$-decomposition of $G(k,n)$ is a set $X$ of copies of $K_k$ in $G(k,n)$ such that each copy of $K_\ell$ in $G(k,n)$ is a subgraph of exactly one copy of $K_k$ in $X$. This paper asks: when does $G(k,n)$ have an $
Fabila-Monroy, Ruy, Wood, David R.
openaire   +2 more sources

Partitioning graphs into complete and empty graphs

open access: yesDiscrete Mathematics, 2009
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Tínaz Ekim, John Gimbel
openaire   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Complete graph immersions in dense graphs [PDF]

open access: yesDiscrete Mathematics, 2017
In this article we consider the relationship between vertex coloring and the immersion order. Specifically, a conjecture proposed by Abu-Khzam and Langston in 2003, which says that the complete graph with $t$ vertices can be immersed in any $t$-chromatic graph, is studied.
openaire   +3 more sources

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy